Company Overview and News

Sensex to be volatile in first half of 2016, 5 stock picks for now

2016-01-27 financialexpress
Experts say this is a time to do some bargain hunting due to attractive valuations.

ITC Q3 net rises to Rs 2,653 cr

New Delhi :  Diversified group ITC Ltd posted a marginal rise in stand-alone net profit at Rs 2,652.8 crore for the third quarter ended December as its cigarette business continued to be under pressure, coupled with a demand slowdown in FMCG segment.

ITC Q3 net marginally up at Rs 2,653 cr

2016-01-22 financialexpress
The company had posted a net profit of Rs 2,635.00 crore during the same period last fiscal.

ITC’s Yippee noodles nears Rs 1k-cr mark, gains from Maggi controversy

2016-01-19 financialexpress
"Sunfeast YiPPee! as a brand is now in its fifth year post the national rollout... We are proud to say that Yippee Noodles is poised to enter the Rs 1,000 crore club in the ITC Foods stable," said ITC Ltd Divisional Chief Executive, Foods Division V L Rajesh.

Domestic Competitors in India%s Personal Care Market ;Analyzing the key local players in a growing personal care market

2016-01-05 prnewswire
NEW YORK, Jan. 5, 2016 /PRNewswire/ -- Summary This report analyzes the strategies of five major personal care...

Why SunPower Corporation and 8point3 Energy Partners Jumped in December

2016-01-05 fool
Congress helped drive these solar stocks higher last month.

Fish & Richardson Named "IP Litigation Department of the Year" Finalist by The American Lawyer

2016-01-05 marketwired
BOSTON, MA--(Marketwired - Jan 5, 2016) - Fish & Richardson announced today that it has been named "IP Litigation Department of the Year" finalist by The American Lawyer. The American Lawyer singled Fish out for this prestigious award because "Fish & Richardson is omnipresent in the IP world -- and...

SolarCity Is Going To Guide 2016 Revenue Growth Lower

2016-01-05 seekingalpha
SolarCity has rallied powerfully due to the extension of the ITC tax credit. However, not all of this extension's consequences have been discounted yet. I argue

SolarCity Corporation's Worst Moves in 2015

2016-01-05 fool
Rising costs and a failed expansion in Nevada have plagued SolarCity lately.

First Solar, Inc.'s Worst Moves in 2015

2016-01-05 fool
First Solar, Inc. was the best-performing large solar company in 2015, but it may not be investing enough to keep that lead for long.

Rewind 2015 Play 2016

2016-01-05 financialexpress
Food & Hospitality World takes a look at the hotel developments of 2015 and the expected growth in the New Year

Canadian Solar Is Set To Dominate In The New Solar Landscape

2016-01-04 seekingalpha
Canadian Solar's leading cost structure and increasingly aggressive manufacturing capacity expansion plans should help the company gain market share in a changi

Why Trina Solar Limited (ADR) Popped 14% in December

2016-01-04 fool
The ITC had solar stocks popping last month, but Trina Solar was up for a different reason entirely.

Turmeric Market in India 2015-2019

2016-01-04 prnewswire
LONDON, Jan. 4, 2016 /PRNewswire/ -- About Turmeric The idea of the use of turmeric is not new in India. Turmeric has...

Patanjali to clock Rs 20,000-cr sales in FY20: IIFL report

2016-01-04 financialexpress
Patanjali, a relatively new FMCG company, is expected to clock sales of Rs 20,000 crore in FY20, resulting in 1-1.5% impact on sales compound annual growth rate (CAGR) for the sector.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

23h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

23h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...